Compare
Medtronic vs ResMed (MDT vs RMD)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Medtronic (MDT) returned +12.6% and ResMed (RMD) -4.0%; so far this year the figures are +6.0% and -2.3%.
Medtronic is the larger company by market value, about 3.9 times the size of ResMed.
On trailing earnings, MDT trades at 25.0 times and RMD at 21.4 times.
Revenue grew +9.8% at MDT and +9.0% at RMD over the last year.
MDT yields 2.81%. RMD yields 1.05%.
Data as of the latest close. Not investment advice.
Relative performance
| MDT | RMD | |
|---|---|---|
| Price | $101.80 | $235.30 |
| 1-day | -2.90% | -1.68% |
| YTD | +5.98% | -2.31% |
| 1 year | +12.61% | -4.05% |
| 3 years | +43.68% | +59.87% |
| Market cap | $130.2B | $33.1B |
| P/E | 25.0 | 21.4 |
| P/S | 3.47 | 5.77 |
| P/B | 2.59 | 5.56 |
| Revenue growth | +9.80% | +9.00% |
| EPS growth | +12.10% | +12.40% |
| Gross margin % | 65.0 | 61.1 |
| Net margin % | 13.9 | 27.8 |
| ROE % | 10.4 | 26.8 |
| Debt / equity | 0.56 | 0.07 |
| FCF yield % | 4.7 | 4.9 |
| Dividend yield % | 2.81 | 1.05 |
| Beta | 0.14 | 0.47 |
| RSI (14) | 63.8 | 48.3 |
| Technical rating |